Sign In
Buy PFE
$26.04
+0.350 (+1.36%)
At Close: Jun 05, 2026
Biden says U.S. turning corner on COVID, but experts are worried that BA.2 is pushing cases higher in 15 states
10:38am, Friday, 01'st Apr 2022 MarketWatch
President Joe Biden said Wednesday the U.S. is turning the page on the COVID-19 pandemic, as his administration took the wraps off a website that aims to help Americans find tests, treatments and othe
Buying Vaccine Stocks? Look at These 2 Charts First
10:00am, Friday, 01'st Apr 2022 The Motley Fool
Coronavirus vaccines generated blockbuster revenue last year.
Pfizer: How It Could Double
04:24am, Friday, 01'st Apr 2022 Seeking Alpha
Since my last report in Oct 2021, consensus earnings estimates for Pfizer have risen 94% and 57% for 2022 and 2023, respectively. Read why PFE could double from here.
Why Novavax Stock Dipped On Thursday
10:19pm, Thursday, 31'st Mar 2022 The Motley Fool
Two outwardly positive developments for the company weren't enough to prevent a minor investor sell-off.
'COVID-19 no longer controls our lives,' Biden says, while rolling out website for living with virus
12:39pm, Thursday, 31'st Mar 2022 MarketWatch
President Joe Biden on Wednesday emphasizes that the country is turning the page on the COVID-19 pandemic, as his administration takes the wraps off a website that aims to help Americans deal with the
J&J (JNJ) Gets FDA Nod for HIV Jab, Cabenuva, in Adolescents
04:28pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
The FDA approves Johnson & Johnson's (JNJ) Cabenuva for treating HIV-1 in virologically suppressed adolescents aged 12 years and above.
3 Charts You Have to See Before Buying Moderna
02:53pm, Wednesday, 30'th Mar 2022 The Motley Fool
Could the gravy train be coming to an end?
5 Charts That Show Why Bristol-Myers Squibb Is a No-Brainer Buy
02:15pm, Wednesday, 30'th Mar 2022 The Motley Fool
The company gives investors plenty of reasons to buy and hold the stock for years.
FDA Authorizes Pfizer, Moderna's Second COVID Booster Dose
01:18pm, Wednesday, 30'th Mar 2022 Zacks Investment Research
The FDA authorized a second booster dose of COVID-19 vaccines made by Pfizer (PFE)/BioNTech (BNTX) and Moderna (MRNA) for older adults and some immunocompromised individuals.
U.S. average daily deaths from COVID fall below 800 to lowest level since mid-August, and FDA allows second booster shot for people 50 and older
11:49am, Wednesday, 30'th Mar 2022 MarketWatch
The average number of daily deaths from COVID-19 in the U.S. has fallen below 800 for the first time since the highly transmissible omicron variant was first detected in the fall, and is now trending
Pfizer (PFE) 2nd Ulcerative Colitis Study on Etrasimod Succeeds
11:43am, Wednesday, 30'th Mar 2022 Zacks Investment Research
Pfizer's (PFE) ELEVATE UC 52 is the second phase III study on etrasimod for ulcerative colitis to have met primary and key secondary endpoints.
Is Novavax Stock a Buy Now?
10:00am, Wednesday, 30'th Mar 2022 The Motley Fool
Two catalysts lie ahead.
Why Moderna and BioNTech Were Winners Today
10:07pm, Tuesday, 29'th Mar 2022 The Motley Fool
The FDA expands its authorization for both companies' coronavirus vaccines.
Pfizer (PFE) Stock Sinks As Market Gains: What You Should Know
09:45pm, Tuesday, 29'th Mar 2022 Zacks Investment Research
Pfizer (PFE) closed the most recent trading day at $52.74, moving -1.01% from the previous trading session.
2 Dirt Cheap Dividend Stocks to Buy Right Now
03:00pm, Tuesday, 29'th Mar 2022 The Motley Fool
These two bargain stocks look like steals right now.
